Evidence map›Paper›PMID 25575595›Full record

ArticleThe Journal of biological chemistry2015

Characterization of the pivotal carbon metabolism of Streptococcus suis serotype 2 under ex vivo and chemically defined in vitro conditions by isotopologue profiling.

Jörg Willenborg, Claudia Huber, Anna Koczula, Birgit Lange, Wolfgang Eisenreich, Peter Valentin-Weigand, Ralph Goethe

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Automated Assignment ofJournal of the American Society for Mass Spectrometry · 2024
    Article
  9. Article
  10. Role of Metabolic Adaptation ofPathogens (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Article
  13. Exogenous glycogen utilization effects the transcriptome and pathogenicity ofFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jörg WillenborgFrom the Institute of Microbiology, University of Veterinary Medicine Hannover, D-30173 Hannover, Germany and joerg.willenborg@tiho-hannover.de.
Claudia Huberthe Lehrstuhl für Biochemie, Technische Universität München, D-85747 Garching, Germany.
Anna KoczulaFrom the Institute of Microbiology, University of Veterinary Medicine Hannover, D-30173 Hannover, Germany and.
Birgit Langethe Lehrstuhl für Biochemie, Technische Universität München, D-85747 Garching, Germany.
Wolfgang Eisenreichthe Lehrstuhl für Biochemie, Technische Universität München, D-85747 Garching, Germany.
Peter Valentin-WeigandFrom the Institute of Microbiology, University of Veterinary Medicine Hannover, D-30173 Hannover, Germany and.
Ralph GoetheFrom the Institute of Microbiology, University of Veterinary Medicine Hannover, D-30173 Hannover, Germany and.
Technical University of Munich · DEUniversity of Veterinary Medicine Hannover, Foundation · DEUniversity of Veterinary Medicine Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus suis is a neglected zoonotic pathogen that has to adapt to the nutritional requirements in the different host niches encountered during infection and establishment of invasive diseases. To dissect the central metabolic activity of S. suis under different conditions of nutrient availability, we performed labeling experiments starting from [(13)C]glucose specimens and analyzed the resulting isotopologue patterns in amino acids of S. suis grown under in vitro and ex vivo conditions. In combination with classical growth experiments, we found that S. suis is auxotrophic for Arg, Gln/Glu, His, Leu, and Trp in chemically defined medium. De novo biosynthesis was shown for Ala, Asp, Ser, and Thr at high rates and for Gly, Lys, Phe, Tyr, and Val at moderate or low rates, respectively. Glucose degradation occurred mainly by glycolysis and to a minor extent by the pentose phosphate pathway. Furthermore, the exclusive formation of oxaloacetate by phosphoenolpyruvate (PEP) carboxylation became evident from the patterns in de novo synthesized amino acids. Labeling experiments with S. suis grown ex vivo in blood or cerebrospinal fluid reflected the metabolic adaptation to these host niches with different nutrient availability; however, similar key metabolic activities were identified under these conditions. This points at the robustness of the core metabolic pathways in S. suis during the infection process. The crucial role of PEP carboxylation for growth of S. suis in the host was supported by experiments with a PEP carboxylase-deficient mutant strain in blood and cerebrospinal fluid.

Indexed as

Amino AcidsAnimalsBacterial ProteinsBiosynthetic PathwaysCarbohydrate MetabolismCarbonCarbon IsotopesCell DivisionCulture MediaDisaccharidesGlucoseGlycolysisMonosaccharidesMutationOxaloacetic AcidPhosphoenolpyruvateAmino AcidsBacterial ProteinsCarbonCarbon IsotopesCulture MediaDisaccharidesGlucoseMonosaccharidesOxaloacetic AcidPhosphoenolpyruvatePhosphoenolpyruvate CarboxylaseAmino AcidBacterial MetabolismBiosynthesisCarbohydrate MetabolismGlycolysisIsotopologue ProfilingPhosphoenolpyruvate CarboxylaseStreptococcus suis

Identifiers

PMID25575595
PMCPMC4342492
OpenAlexW2014699742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.